Cas No.: | 17019-92-0 |
Chemical Name: | 11-Keto-beta-boswellic acid |
Synonyms: | 11-Keto-beta-boswellic acid;11-Keto β-Boswellic Acid;11-Keto-ß-boswellic acid;11-Keto-β-boswellic acid;Beta-boswellic acid,11-keto;KETO-B-BOSWELLIC ACID, 11-(P);Urs-12-en-23-oic acid,3-hydroxy-11-oxo-, (3a,4b)-;Beta-boswellic acid;KBA;11-Oxo-β-boswellic Acid;β-Boswellic acid,11-keto;KETO-B-BOSWELLIC ACID, 11-(SH);3-Hydroxy-11-oxo-12-ursen-24-oic acid;3α-Hydroxy-11-oxours-12-en-24-oic Acid;(3α,4β)-3-Hydroxy-11-oxours-12-en-23-oic Acid;11-keto-beta-boswellicacid;(4R,4Ar,6aR,6bS,8aR,12aR,14aS,14bS)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7;(4R,4Ar,6aR,6bS,8aR,12aR,14aS,14bS)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid;(4R,6aR,6bS,8aR,14bS)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12, |
SMILES: | O([H])C1([H])C([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C([H])([C@]1(C(=O)O[H])C([H])([H])[H])C([H])([H])C([H])([H])[C@]1(C([H])([H])[H])C2([H])C(C([H])=C2C3([H])C([H])(C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]12C([H])([H])[H])=O |
Formula: | C30H46O4 |
M.Wt: | 470.6838 |
Purity: | >98% |
Sotrage: | 4°C for 1 year, -20°C for more than 2 years |
Description: | 11-Keto-beta-boswellic acid (11-Keto-β-boswellic acid) is a pentacyclic triterpenic acid of the oleogum resin from the bark of the Boswellia serrate tree, popularly known as Indian Frankincense. 11-Keto-beta-boswellic acid has the anti-inflammatory activity is primarily due to inhibit 5-lipoxygenase and subsequent leukotriene and nuclear factor-kappa B (NF-κB) activation and tumor necrosis factor alpha generation production[1]. |
References: | [1]. Miscioscia E, et al. Measurement of 3-acetyl-11-keto-beta-boswellic acid and 11-keto-beta-boswellic acid in Boswellia serrata Supplements Administered to Dogs. BMC Vet Res. 2019 Aug 1;15(1):270. |